Sign in

CIK 0001621227

  • Non-accelerated filer
  • Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1235430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Director sold 18,700 shares at an average $13.56 ($253,631)
  7. 4 Open-market sale Director sold 18,700 shares at an average $13.56 ($253,631)
  8. 4 Open-market sale Director sold 171,000 shares at an average $13.51 ($2,310,420)
  9. 4 Open-market sale Director sold 171,000 shares at an average $13.51 ($2,310,420)
  10. 4 Open-market sale Director sold 10,300 shares at $13.50 ($139,050)
  11. 4 Open-market sale Director sold 10,300 shares at $13.50 ($139,050)
  12. 4 Open-market sale Director sold 1,048,067 shares at an average $11.50 ($12,053,730)
  13. 4 Open-market sale Director sold 1,048,067 shares at an average $11.50 ($12,053,730)
  14. 4 Open-market buy 10% owner bought 6,571,164 shares at an average $1.92 ($12,587,753)
  15. 4 Open-market buy 10% owner bought 6,571,164 shares at an average $1.92 ($12,587,753)
  16. 4 Open-market buy 10% owner bought 6,571,164 shares at an average $1.92 ($12,587,753)
  17. 4 Open-market buy Director bought 6,571,164 shares at an average $1.92 ($12,587,753)
  18. 4 Open-market buy 10% owner bought 6,571,164 shares at an average $1.92 ($12,587,753)
  19. 4 Open-market buy 10% owner bought 6,571,164 shares at an average $1.92 ($12,587,753)
  20. 4 Open-market buy 10% owner bought 6,571,164 shares at an average $1.92 ($12,587,753)

Page 13 of 18 · 351 filings